Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE

Molecular Medicine

Volumn 7, Issue 3, 2001, Pages 159-168

  He, Ci Jiang ^a   Koschinsky, Theodore ^b   Buenting, Christina ^b   Vlassara, Helen ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; MESSENGER RNA; PRIMER DNA;

ADULT; ANIMAL; ARTICLE; BLOOD; FEMALE; GENETICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; MONOCYTE; MOUSE; NONOBESE DIABETIC MOUSE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 1; DNA PRIMERS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MACROPHAGES; MALE; MICE; MICE, INBRED NOD; MIDDLE AGED; MONOCYTES; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0035293890     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401949     Document Type: Article

References (45)

1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetics: an epidemiological study. Diabetologia 25: 496-501.
2. Krolewski AS, Canessa M, Warram JH, Laffel LM, Christlieb AS, Knowler WC, Rand LI. (1988) Predisposition to hypertension and susceptability to renal disease in insulin-dependent diabetes mellitus. N. Engl. J Med 318: 140-145.
3. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS. (1998) Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 47: 1164-1170.
4. Seaquist ER, Goetz FC, Rich S, Barbosa J. (1989) Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N. Engl. J. Med. 320: 1161-1165.
5. Ng LL, Davies JE, Siczhowski MM, Sweeney FP, Quinn PA, Krolewski B, Krolewski AS. (1994) Abnormal Na+/H+ antiporter phenotyope and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy. J. Clin. Invest 93: 2750-2757.
6. Parving H-H. (1998). Renoprotection in diabetes: genetic and non-genetic risk factors and treatment. Diabetologia 41: 745-759.
7. Doria A, Warram JH, Krolewski A. (1994) Evidence for the role of the angiotensin I-converting enzyme gene. Diabetes 43: 690-695.
8. Ruderman NB, Williamson JR, Brownlec M. (1992) Glucose and diabetic vascular disease. FASEB J 6: 2905-2914.
9. Brownlee M. (1995) Advanced protein glycosylation in diabetes and aging. Annu. Rev Med. 46: 223-234.
10. Schmidt AM, Yan SD, Wautier J-L, Stern D. (1999) Activation of receptor for advanced glycation end products, a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res 84: 489-497.
11. Yang Z, Makita Z, Horii Y, Brunelle S, Cerami A, Sephajpal P, Suthanthiran M, Vlassara H. (1991) Two novel rat liver membrane proteins that bind advanced glycosylation enproducts: relationship to macrophage receptor for glucose-modified proteins. J Exp. Med. 174: 515-524.
12. Li Y-M, Mitsuhashi T, Wojciehowicz D, et al. (1996) Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc Natl. Acad. Sci. USA 93: 11047-11052.
13. Goh KC, Lim YP, Ong SH, Siak CB, Cao X, Tan YH, Guy GR. (1996) Identification of p90, a prominent tyrosine-phosphorylated protein in fibroblast growth factor stimulated cells, as 80K-H. J. Biol Chem. 271: 5832-5838.
14. Sakai K, Hirai M, Minoshima S, Kidoh J, Fukuyama R, Shimizu N. (1989) Isolation of cDNAs encoding a substate for protein kinase C: nucleotide sequence and chromosomal mapping of the gene for a human 80K-H protein. Genomics 5: 309-315.
15. Stitt A, He C, Vlassara H. (1999) Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells. Biochem Biophys. Res. Comm 256: 549-556.
16. Vlassara H, Li YM, Imani F, Wojciechowicz D, Yang Z, Liu F, Cerami A. (1995) Identification of galectin-3 as a high affinity binding protein for advanced glycation enproducts (AGE): a new member of the AGE-receptor complex. Mol Med. 1: 634-646.
17. Kadrofske M, Openo KP, Wang JL. (1998) The human LGALS3 (galectin-3) gene: determination of the gene structure and functional characterization of the promoter. Arch. Biochem. Biophys 349: 7-20.
18. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H. (1997) Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J. Pathol. 150: 523-539.
19. Neeper M, Schmidt AM, Brett J, et al. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol Chem 267: 14998-15004.
20. Landers HM, Tauras JM, Ogiste JS. (1989) Isolation of cDNAs encoding a substate for protein kinase C: nucleotide sesquence and chromosomal mapping of the gene for a human 80K-H protein. J Biol. Chem. 272: 17810-17814.
21. Khoury J, Thomas C, Loike J, Hickman S, Cao L, Silverstein S. (1994) Macrophages adhere to glucose-modified basement membrane via their scavenger receptors. J. Biol. Chem. 269: 10197-10200.
22. Suzuki H, Kurihara Y, Takeya M, et al. (1997) A role for macrophage scavenger receptors in artherosclerosis and susceptibility to infection. Nature 386: 292-296.
23. Yamagata T, Tsuru T, Momoi M, et al. (1997) Genome Organization of Human 48-kDa Oligosaccharryltranferase (DDOST). Genomics 45: 535-540.
24. Hudson BI, Stickland MH, Grant PJ. (1998) Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) Gene, Diabetes 47: 1155-1157.
25. Vlassara H, Brownlee M, Cerami A. (1988). Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo. Diabetes 37: 456-461.
26. Stitt AW, He C, Friedman S, et al. (1997) Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med. 3: 617-627.
27. Sano H, Higashi T, Matsumoto K, et al. (1998) Insulin enhances macrophage scavenger receptor-mediated endocytic uptake of advanced glycation end products. J. Biol. Chem. 273: 8630-8637.
28. Vlassara H, Moldawer L, Chan C. (1989) Macrophage/monocyte receptor for nonenzymatically glycosylated protein is up-regulated by cachectin/tumor necrosis factor. J. Clin. Invest. 84: 1813-1820.
29. Vlassara H, Bucala R, Striker L. (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 70: 138-151.
30. Shinohara M, Thornalley PJ, Giardino I, Beisswenger P, Thrope SR, Onorato J, Brownlee M. (1998) Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 101: 1142-1147.
31. Cohen MP, Ziyadeh FN, Lautenslager GT, Cohen JA, Shearman CW. (1999) Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells. Am. J Physiol 276: F684-690.
32. Vlassara H. (1989) Advanced non-enymatic tissue glycosylation: mechanism implicated in the complications associated with aging. In: Clegg M, O'Brien S (eds) Molecular Biology of Aging. Alan R. Liss, Inc., New York, pp. 171-185.
33. Makita Z, Radoff S, Rayfield EJ, et al. (1991) Advanced Glycation Enproducts in patients with diabetic nephropathy. N. Engl. J. Med. 325: 836-842.
34. Makita Z, Bucala R, et al. (1994) Reactive glycosylation end-products in diabetic uraemia and treatment of renal failure. Lancet 343: 1519-1522.
35. Doi T, Hattori M, Agodoa LY, Sato T, Yoshida H, Striker LJ, Striker GE. (1990) Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab Invest. 63: 204-212.
36. Yang CW, Hattori M, Vlassara H, et al. (1995) Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice. J. Am. Soc Nephrol. 5: 1610-1617.
37. He C, Zheng F, Stitt A, Striker L, Masakazu H, Vlassara H. (2000) Differential expression of renal AGE-receptor genes in NOD mice; possible role in NOD diabetic renal disease. Kidney Int. (in press).
38. He C, Stitt A, Striker L, Hatori M, Vlassara H. (1996) Low expression of AGE-receptor-1 in NOD mouse mesangial cells: possible link to diabetic nephropathy. J. Am. Soc. Nephrol. 7: 1871 (Abstr).
39. He C, Koschinsky T, Sabol J, Buenting C, Liu C, Vlassara H. (1997) Mononuclear (MN) cell AGE receptor-1 (AGE-R1) mRNA expression and its relationship to diabetic complications. Diabetes Supplement. 46: 8A (Abstr).
40. Leong LN, Davies JE, Siczowski M, Sweeney FP, Quinn PA, Krolewski B, Krolewski AS. (1994) Abnormal Na+/H+ antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetes patients with nephropathy. J. Clin. Invest. 93: 2750-2757.
41. Rogus JJ, Krolewski AS. (1996) Using discordant sib pairs to map loci for qualitative traits with high sibling recurrence risk. Am J Hum. Genet. 59: 1376-1381.
42. Beisswenger PJ, Makita Z, Curphey TJ, et al. (1995) Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44: 824-829.
43. Makita Z, Vlassara H, Cerami A, Bucala B. (1992) Immuno-chemical detection of advanced glycosylation end products in vivo. J Biol. Chem. 267: 5133-5138.
44. Zyzak DV, Richardson JM, Thorpe SR, Baynes JW. (1995) Formation of reactive intermediates from Amadori compounds under physiological conditions. Arch. Biochem Biophys, 316: 547-554.
45. Quinn M, Angelico MC Warram JH, Krolewski AS. (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39: 940-945.